EP Wealth Advisors’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,860
Closed -$2.9M 693
2023
Q1
$2.9M Sell
2,860
-9,588
-77% -$184K 0.05% 196
2022
Q4
$203K Sell
12,448
-354
-3% -$5.25K ﹤0.01% 548
2022
Q3
$180K Hold
12,802
﹤0.01% 310
2022
Q2
$319K Hold
12,802
0.01% 468
2022
Q1
$431K Hold
12,802
0.01% 408
2021
Q4
$416K Hold
12,802
0.01% 392
2021
Q3
$448K Hold
12,802
0.01% 351
2021
Q2
$532K Hold
12,802
0.01% 326
2021
Q1
$472K Hold
12,802
0.02% 337
2020
Q4
$532K Hold
12,802
0.02% 256
2020
Q3
$544K Buy
+12,802
New +$552K 0.02% 216
2020
Q2
Sell
-12,802
Closed -$506K 232
2020
Q1
$420K Buy
+12,802
New +$476K 0.02% 271

Other funds holding FMS

EP Wealth Advisors's FMS Position: Q2 2023 in Review

EP Wealth Advisors sold out of Fresenius Medical Care (FMS) in Q2 2023, closing a stake of 2,860 shares — an estimated $2.9M sold.

EP Wealth Advisors first reported a position in FMS in Q1 2020 and held it in 12 quarters. The position peaked at $2.9M in Q1 2023. 146 funds tracked by Wall St. Rank hold FMS as of Q2 2023.

  • EP Wealth Advisors reported no remaining Fresenius Medical Care position as of Q2 2023 after selling out during the quarter.
  • EP Wealth Advisors sold 2,860 Fresenius Medical Care shares in Q2 2023, an estimated $2.9M.
  • EP Wealth Advisors first reported a position in Fresenius Medical Care in Q1 2020 and held it in 12 quarters.
  • EP Wealth Advisors's Fresenius Medical Care position peaked at $2.9M in Q1 2023.
  • 146 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2023.

Based on EP Wealth Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.